Form 4: Johnson & Johnson Director Acquires Deferred Share Units

Mary C. Beckerle, a director at Johnson & Johnson, acquired deferred share units under the company's Amended and Restated Deferred Fee Plan for Directors.

Summary

• On April 25, 2024, Mary C. Beckerle, a director of Johnson & Johnson, acquired 1,385.697 deferred share units (DSUs) under the Issuer's Amended and Restated Deferred Fee Plan for Directors.
• These DSUs will be settled in cash upon termination of Beckerle's directorship, with each DSU representing the fair market value of one share of Common Stock on the settlement date.
• Following the transaction, Beckerle beneficially owns 13,643.012 derivative securities, which includes dividend equivalent rights accrued on the DSUs.
• The transaction was reported on April 29, 2024.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing related to director compensation. It doesn't contain information that would significantly impact investor sentiment positively or negatively.

Future Outlook

The deferred share units will be settled in cash upon termination of the Reporting Person's directorship.

Industry Context

This filing is a routine disclosure of a director's acquisition of deferred share units, a common form of compensation for board members in publicly traded companies.

Stakeholder Impact

• The acquisition of deferred share units by a director aligns their interests with those of shareholders, as the value of the units is tied to the company's stock performance.

Key Dates